ecrin-mdr-crcClinical2023IPD Sharing (as of March 2023): NoHER2-positive Colorectal CancerHER2-positive Gastric CancerHER2 Low Breast CancerHER2-positive TumorsHER2-positive Non-Small Cell Lung CancerBreast NeoplasmsHER2-positive Breast CancerHer2-positive TumorsHer2-positive Non-small Cell Lung CancerHer2-positive Colorectal CancerHer2-positive Gastric CancerHer2 Low Breast CancerHer2-positive Breast CancerBreast NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2746280United States1ECRIN MDRSuspendedfalseA Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2A Study of XMT-2056 in advanced/recurrent solid tumors that express HER2.2023-01-152746280NCT05514717